{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T10:32:51Z","timestamp":1742380371266},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,20]]},"DOI":"10.7759\/cureus.20541","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T17:31:56Z","timestamp":1640021516000},"source":"Crossref","is-referenced-by-count":1,"title":["Unmasking of Myasthenia Gravis After Introduction of Oral Risperidone in a Schizophrenic Saudi Male: A Case Report"],"prefix":"10.7759","author":[{"given":"Lamees","family":"Abualkhair","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Almaghrabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nada","family":"Al Edrees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Hassab Errasoul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3233\/jnd-140045","article-title":"The epidemiology of neuromuscular disorders: a comprehensive overview of the literature","volume":"2","author":"Deenen J","year":"2015","unstructured":"Deenen J, Horlings C, Verschuuren J, Verbeek A, van Engelen B. The epidemiology of neuromuscular disorders: a comprehensive overview of the literature. J Neuromuscul Dis. 2015, 2:73-85. 10.3233\/jnd-140045","journal-title":"J Neuromuscul Dis"},{"key":"ref2","article-title":"Myasthenia gravis","author":"Suresh AB","year":"2021","unstructured":"Suresh AB, Asuncion RM. Myasthenia gravis. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2021."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2019.3360","article-title":"Schizophrenia-an overview","volume":"77","author":"McCutcheon RA","year":"2020","unstructured":"McCutcheon RA, Marques TR, Howes OD. Schizophrenia-an overview. JAMA Psychiatry. 2020, 77:201-10. 10.1001\/jamapsychiatry.2019.3360","journal-title":"JAMA Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s0028-3908(02)00018-7","article-title":"Effects of atypical antipsychotics on vertebrate neuromuscular transmission","volume":"42","author":"Nguyen Q","year":"2002","unstructured":"Nguyen Q, Yang J, Miledi R. Effects of atypical antipsychotics on vertebrate neuromuscular transmission. Neuropharmacology. 2002, 42:670-6. 10.1016\/s0028-3908(02)00018-7","journal-title":"Neuropharmacology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.163.3.521","article-title":"Association of schizophrenia and autoimmune diseases: linkage of Danish national registers","volume":"163","author":"Eaton WW","year":"2006","unstructured":"Eaton WW, Byrne M, Ewald H, Mors O, Chen CY, Agerbo E, Mortensen PB. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry. 2006, 163:521-8. 10.1176\/appi.ajp.163.3.521","journal-title":"Am J Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2018.06.016","article-title":"Associations between non-neurological autoimmune disorders and psychosis: a meta-analysis","volume":"85","author":"Cullen AE","year":"2019","unstructured":"Cullen AE, Holmes S, Pollak TA, et al.. Associations between non-neurological autoimmune disorders and psychosis: a meta-analysis. Biol Psychiatry. 2019, 85:35-48. 10.1016\/j.biopsych.2018.06.016","journal-title":"Biol Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000741","article-title":"Worsening of myasthenia gravis after administration of antipsychotics for treatment of schizophrenia: a case report and review of literature","volume":"37","author":"She S","year":"2017","unstructured":"She S, Yi W, Zhang B, Zheng Y. Worsening of myasthenia gravis after administration of antipsychotics for treatment of schizophrenia: a case report and review of literature. J Clin Psychopharmacol. 2017, 37:620-2. 10.1097\/JCP.0000000000000741","journal-title":"J Clin Psychopharmacol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5152\/eurasianjmed.2018.17296","article-title":"Myasthenia gravis attack after oral risperidone treatment: a case report","volume":"50","author":"Ogutlu H","year":"2018","unstructured":"Ogutlu H, Karayagmurlu A, Esin IS, Dursun OB. Myasthenia gravis attack after oral risperidone treatment: a case report. Eurasian J Med. 2018, 50:128-9. 10.5152\/eurasianjmed.2018.17296","journal-title":"Eurasian J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10071537","article-title":"Drugs that induce or cause deterioration of myasthenia gravis: an update","volume":"10","author":"Sheikh S","year":"2021","unstructured":"Sheikh S, Alvi U, Soliven B, Rezania K. Drugs that induce or cause deterioration of myasthenia gravis: an update. J Clin Med. 2021, 10:10.3390\/jcm10071537","journal-title":"J Clin Med"},{"key":"ref10","article-title":"Myasthenia in a patient with sarcoidosis and schizophrenia","volume":"57","author":"R\u00f3zsa C","year":"2004","unstructured":"R\u00f3zsa C, Kis G, Komoly S, et al.. Myasthenia in a patient with sarcoidosis and schizophrenia. Ideggyogy Sz. 2004, 57:242-4.","journal-title":"Ideggyogy Sz"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2009.12.019","article-title":"Myasthenia gravis and respiratory failure in a patient with schizophrenia","volume":"34","author":"Shiao WK","year":"2010","unstructured":"Shiao WK, Bai YM, Su TP. Myasthenia gravis and respiratory failure in a patient with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2010, 34:548-9. 10.1016\/j.pnpbp.2009.12.019","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1329200","article-title":"Myasthenia gravis","volume":"32","author":"Silvestri NJ","year":"2012","unstructured":"Silvestri NJ, Wolfe GI. Myasthenia gravis. Semin Neurol. 2012, 32:215-26. 10.1055\/s-0032-1329200","journal-title":"Semin Neurol"},{"key":"ref13","article-title":"Extrapyramidal symptoms","author":"D'Souza RS","year":"2021","unstructured":"D'Souza RS, Hooten WM. Extrapyramidal symptoms. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2021."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/pnp.264","article-title":"Myasthenia gravis unmasked by antipsychotic medication","volume":"17","author":"Wilson C","year":"2013","unstructured":"Wilson C, Ferguson J. Myasthenia gravis unmasked by antipsychotic medication. Prog Neurol Psychiatry. 2013, 17:17-9. 10.1002\/pnp.264","journal-title":"Prog Neurol Psychiatry"},{"key":"ref15","article-title":"Risperidone","author":"McNeil SE","year":"2021","unstructured":"McNeil SE, Gibbons JR, Cogburn M. Risperidone. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2021."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2016.02.006","article-title":"Worsening of myasthenia gravis after administration of injectable long-acting risperidone for treatment of schizophrenia; first case report and a call for caution","volume":"26","author":"Al-Hashel JY","year":"2016","unstructured":"Al-Hashel JY, Ismail II, John JK, Ibrahim M, Ali M. Worsening of myasthenia gravis after administration of injectable long-acting risperidone for treatment of schizophrenia; first case report and a call for caution. Neuromuscul Disord. 2016, 26:309-11. 10.1016\/j.nmd.2016.02.006","journal-title":"Neuromuscul Disord"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/78756-unmasking-of-myasthenia-gravis-after-introduction-of-oral-risperidone-in-a-schizophrenic-saudi-male-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:19Z","timestamp":1707507259000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/78756-unmasking-of-myasthenia-gravis-after-introduction-of-oral-risperidone-in-a-schizophrenic-saudi-male-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,20]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.20541","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,20]]}}}